Condition

Smouldering Myeloma (3)

MGUS (1)

Monoclonal Gammopathy of Undetermined Significance (MGUS) (1)

Multiple Myeloma (1)

Myeloma (1)

Overall Status

Recruiting (2)

Completed (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Oxford University Hospitals NHS Trust (1)

Stichting Hemato-Oncologie voor Volwassenen Nederland (1)

University College, London (1)

Collaborator

Amgen (1)

Cancer Research UK (1)

Intervention

bloods and urine (1)

carfilzomib (1)

dexamethasone (1)

diffusion weighted magnetic resonance imaging (dwmri) (1)

dxa scan (1)

lenalidomide (1)

no intervention (1)

Study Documents

Intervention Type

other (2)

drug (1)

Funder Type

Other (3)

Study Type

Observational (2)

Interventional (1)

smouldering myeloma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Smouldering Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone, Lenalidomide)

Recruiting

Smouldering Myeloma

Carfilzomib
+2 more

Brno, Czechia
+15 more

Mar 22, 2022

Biology and Genetics of Smouldering Myeloma

Recruiting

Smouldering Myeloma
+2 more

No intervention

London, United Kingdom

University College London Hospitals

Sep 15, 2021

The Development and Pilot Testing ofNew MR Imaging Protocol to

Completed

Myeloma
+2 more

Diffusion Weighted Magnetic Resonance Imaging (DWMRI)
+2 more

Oxford, Oxfordshire, United Kingdom

Churchill Hospital

Feb 4, 2021